Lumiracoxib | Interleukin Related interleukin-related.com

Product Name :
Lumiracoxib

Search keywords :
Lumiracoxib

drugId :
null

Target Vo:
Cyclooxygenase-2

Target Vo Short Name :
COX-2

Moa_Name:
Cyclooxygenase-2 inhibitors

First Approval Country :
Mexico

First Approval Date Filter:
2003

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Novartis Pharma Ag

Active Indication_Name:
Osteoarthritis

In Active Indication_Name:
Arthritis

Termination Status :

China Termination Status :
Clinical

Highest Status:
Approved

China Highest Status:
Discontinued

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Clathrin heavy chain Antibody
Laminin beta 1 Antibody
ICAM1 Antibody (YA725): ICAM1 Antibody (YA725) is a non-conjugated and Mouse origined monoclonal antibody about 58 kDa, targeting to ICAM1. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts